New Indication: Trastuzumab Deruxtecan in HER2-Low Advanced Breast Cancer
|New Indication: Trastuzumab Deruxtecan in HER2-Low Advanced Breast Cancer|
N Engl J Med 2022 Jun 5. doi: 10.1056/NEJMoa2203690.
Modi, Shanu et al. “Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.”
Reviewed by Hasan Çağrı Yıldırım, MD on Jul 05, 2022
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.